Christoph Brackmann
Vermogen: 3 M $ op 31-05-2026
Vermogen: 3 M $ op 31-05-2026
Christoph Brackmann is Chief Financial Officer at NovoCure Ltd. since 2025.
Former roles include Global Head-IR & Head-Finance International at Shire Plc from 2017 to 2018, and Senior Vice President-Finance at Moderna, Inc. Education includes an undergraduate degree from the University of Mannheim and an MBA from SDA Bocconi School of Management.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
NOVOCURE LTD. 0,16% | 06-04-2026 | 188.144 ( 0,16% ) | 3 M $ | 31-05-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| NOVOCURE LIMITED | Financieel Directeur/CFO | 01-01-2025 |
| Bedrijven | Functie | Einde |
|---|---|---|
| MODERNA, INC. | Corporate Officer/Principal | - |
| SHIRE | Public Communications Contact | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 5 |
|---|---|
Shire Plc
Shire Plc Pharmaceuticals: MajorHealth Technology Develops and markets medicines for patients with rare diseases | Health Technology |
University of Mannheim
University of Mannheim Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
NovoCure Ltd.
NovoCure Ltd. Medical SpecialtiesHealth Technology Operates as a commercial-stage oncology company | Health Technology |
SDA Bocconi School of Management
SDA Bocconi School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Moderna, Inc.
Moderna, Inc. BiotechnologyHealth Technology Researches, develops, manufactures and commercializes mRNA-based respiratory & other virus vaccines, oncology and rare disease therapeutics | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau